Literature DB >> 9835353

The molecular biology of Oct-4 in the early mouse embryo.

C E Ovitt1, H R Schöler.   

Abstract

Preimplantation development in the mouse is characterized by the occurrence of several critical genetic and epigenetic events. Until recently, very little was known about the regulation of these events. The search for genes which are involved in the control of the earliest stages of mouse development has so far resulted in only a few candidates. Oct-4, a member of the POU transcription factor family, is encoded by a gene belonging to this group. Initially present as a maternal factor in the oocyte, Oct-4 is expressed by the embryo throughout the preimplantation period, as well as in germ cell precursors of adult mice. Oct-4 expression is correlated with an undifferentiated phenotype, both in the embryo and in cell lines derived from it. Regulation of the Oct-4 gene is dependent on the activity of two separate enhancers, one of which is specifically active in pluri- and totipotent cells. Its function as a transcriptional regulator is supported by the identification of an increasing number of potential target genes, including some known to be essential for early embryonic development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9835353     DOI: 10.1093/molehr/4.11.1021

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  51 in total

1.  Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity.

Authors:  A Brehm; K Ohbo; W Zwerschke; V Botquin; P Jansen-Dürr; H R Schöler
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.

Authors:  T Ezashi; D Ghosh; R M Roberts
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

3.  Comparative epigenetic analysis of Oct4 regulatory region in RA-induced differentiated NT2 cells under adherent and non-adherent culture conditions.

Authors:  Raha Favaedi; Maryam Shahhoseini; Mohammad Reza Akhoond
Journal:  Mol Cell Biochem       Date:  2011-12-09       Impact factor: 3.396

Review 4.  Advances in reprogramming somatic cells to induced pluripotent stem cells.

Authors:  Minal Patel; Shuying Yang
Journal:  Stem Cell Rev Rep       Date:  2010-09       Impact factor: 5.739

5.  Cdk2ap1 is required for epigenetic silencing of Oct4 during murine embryonic stem cell differentiation.

Authors:  Amit M Deshpande; Yan-Shan Dai; Yong Kim; Jeffrey Kim; Lauren Kimlin; Kai Gao; David T Wong
Journal:  J Biol Chem       Date:  2008-12-31       Impact factor: 5.157

6.  Role of SF-1 and DAX-1 during differentiation of P19 cells by retinoic acid.

Authors:  Bryan W Teets; Kenneth J Soprano; Dianne Robert Soprano
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

7.  Derivation of Rabbit Embryonic Stem Cells from Vitrified-Thawed Embryos.

Authors:  Fuliang Du; Chien-Hong Chen; Yi Li; Yeshu Hu; Li-You An; Lan Yang; Jifeng Zhang; Y Eugene Chen; Jie Xu
Journal:  Cell Reprogram       Date:  2015-11-18       Impact factor: 1.987

8.  Isolation of Oct4-expressing extraembryonic endoderm precursor cell lines.

Authors:  Bisrat G Debeb; Vasiliy Galat; Jessica Epple-Farmer; Steve Iannaccone; Wendy A Woodward; Michael Bader; Philip Iannaccone; Bert Binas
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

9.  Promoter analysis of the rabbit POU5F1 gene and its expression in preimplantation stage embryos.

Authors:  Julianna Kobolak; Katalin Kiss; Zsuzsanna Polgar; Solomon Mamo; Claire Rogel-Gaillard; Zsuzsanna Tancos; Istvan Bock; Arpad G Baji; Krisztina Tar; Melinda K Pirity; Andras Dinnyes
Journal:  BMC Mol Biol       Date:  2009-09-04       Impact factor: 2.946

10.  EWS-Oct-4B, an alternative EWS-Oct-4 fusion gene, is a potent oncogene linked to human epithelial tumours.

Authors:  S Kim; B Lim; J Kim
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.